Status:
COMPLETED
Efficacy of Amodiaquine in the Treatment of Uncomplicated Falciparum Malaria in Young Children of Burkina Faso
Lead Sponsor:
Heidelberg University
Collaborating Sponsors:
Centre de Recherche en Sante de Nouna, Burkina Faso
Conditions:
Malaria
Eligibility:
All Genders
6-59 years
Phase:
PHASE2
Brief Summary
Design: Single-centre Indication: Malaria caused by Plasmodium falciparum Objectives: To determine and compare the efficacy of AQ treatment in young children with uncomplicated falciparum malaria in ...
Eligibility Criteria
Inclusion
- Age 6-59 months
- Uncomplicated falciparum malaria (axillary temperature ≥ 37.5°C and ≥ 2.000 P. falciparum asexual parasites per µl blood)
- Written informed consent given by the parents/caretakers
Exclusion
- Complicated or severe malaria (repeated vomiting, seizures or other neurological impairment, haemoglobin \< 7 g/dl or haematocrit \< 21%)
- Any apparent significant disease (e. g. pneumonia, meningitis, hepatitis, severe diarrhoea, measles, severe malnutrition)
- Malaria treatment with western drugs and/or antibiotics with anti malarial potency during last 7 days except chloroquine.
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
End Date :
November 1 2005
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00261222
Start Date
September 1 2005
End Date
November 1 2005
Last Update
February 3 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de Recherche en Santé de Nouna (CRSN)
Nouna, Burkina Faso, P.O. Box 34